Jci_page_head_homepage_01 Jci_page_head_homepage_02
Xueliang Du, Diane Edelstein, Silvana Obici, Ninon Higham, Ming-Hui Zou,, Michael Brownlee
Published in Volume 116, Issue 4
J Clin Invest. 2006; 116(4):1071–1080 doi:10.1172/JCI23354
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 9
Effect of inhibitors of lipolysis, CPT-1, and ROS on arterial eNOS inactivation in 2 animal models of insulin resistance.

(A) Effect of FFA-induced ROS production on eNOS activity in insulin-resistant fa/fa rat aortae. Enzyme activity was determined in lean controls (FA/fa), fa/fa rats, and fa/fa rats treated with the SOD mimetic MnTBAP, the antilipolytic agent NA, or the CPT-I inhibitor etomoxir. Each bar represents the mean plus SEM of 6 rats per group. *P < 0.01 compared with lean controls. (B) Effect of FFA-induced ROS production on eNOS activity in high-fat diet–induced insulin-resistant mouse aortae. Enzyme activity was determined in standard-diet controls, high-fat diet–induced insulin-resistant mice, and high-fat diet–induced insulin-resistant mice treated with the SOD mimetic MnTBAP, the antilipolytic agent NA, or the CPT-I inhibitor etomoxir. Each bar represents the mean plus SEM of 6 mice per group. *P < 0.01 compared with controls.